Pancreatic Neoplasms
Showing NaN - NaN of 9
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- LY3537982
- +7 more
-
Los Angeles, California
- +21 more
Jul 22, 2022
Pancreatic Tumors, Pancreatitis, Pancreatic Cyst Trial in Los Angeles (EUS enhanced with contrast to evaluate pancreas)
Recruiting
- Pancreatic Neoplasms
- +2 more
- EUS enhanced with contrast to evaluate pancreas
-
Los Angeles, CaliforniaLos Angeles County Hospital
Dec 6, 2021
Pancreatic Tumors Trial in Los Angeles (EUS with Fiducial)
Recruiting
- Pancreatic Neoplasms
- EUS with Fiducial
-
Los Angeles, CaliforniaLos Angeles County Hospital
Nov 16, 2021
Weight Stability of Pancreatic Cancer Cachexia Patients
Completed
- Pancreatic Neoplasms
- +3 more
- Tube feeding
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 9, 2020
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013